ciprofloxacin has been researched along with salicylates in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallicano, K; Garber, G; Oliveras, L; Rambout, L; Sahai, J | 1 |
| Farkas, H; Füst, G; Gyeney, L; Majthényi, P; Varga, L | 1 |
| Berlanga, M; Viñas, M | 1 |
| Kovalenko, AN; Lobzin, IuV | 1 |
| Burns, JL; Cheung, KJ; Griffith, A; Nair, BM | 1 |
| Amicosante, G; Becerro, P; De Anta, MT; Perilli, M; Ruiz, J; Tavío, MM; Vila, J | 1 |
| Dunzendorfer, T; Johnson, R; Wilkins, S | 1 |
| Ibañez, GA; Lozano, VA; Olivieri, AC; Tauler, R | 1 |
| Hartog, E; Kler, E; Menashe, O; Yaron, S | 1 |
| Alcaraz, MR; Culzoni, MJ; Ibañez, GA; Lozano, VA; Olivieri, AC | 1 |
1 trial(s) available for ciprofloxacin and salicylates
| Article | Year |
|---|---|
Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Bismuth; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Organometallic Compounds; Salicylates | 1994 |
9 other study(ies) available for ciprofloxacin and salicylates
| Article | Year |
|---|---|
Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection.
Topics: Adult; Angioedema; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Ciprofloxacin; Complement C1 Inactivator Proteins; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Salicylates; Time Factors | 1999 |
Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Resistance, Microbial; Lipopolysaccharides; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Salicylates; Serratia marcescens | 2000 |
[Combined infection of abdominal typhoid and hepatitis A and E].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Diagnosis, Differential; Endemic Diseases; Hepatitis A Virus, Human; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Male; Ofloxacin; Salicylates; Tajikistan; Typhoid Fever | 2003 |
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia).
Topics: Bacterial Outer Membrane Proteins; Burkholderia cepacia complex; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Profiling; Humans; Infant; Multigene Family; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Sequence Analysis, DNA; Trimethoprim | 2004 |
Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
Topics: 2,4-Dinitrophenol; beta-Lactamases; beta-Lactams; Ciprofloxacin; Citrobacter freundii; Drug Resistance, Bacterial; Enzyme Induction; Humans; Salicylates | 2005 |
Mucosal tear in collagenous colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Biopsy; Bismuth; Budesonide; Ciprofloxacin; Colitis, Collagenous; Colonoscopy; Enema; Female; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 2009 |
Standard addition analysis of fluoroquinolones in human serum in the presence of the interferent salicylate using lanthanide-sensitized excitation-time decay luminescence data and multivariate curve resolution.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Lanthanoid Series Elements; Luminescent Measurements; Norfloxacin; Salicylates; Terbium | 2009 |
Salicylate reduces the antimicrobial activity of ciprofloxacin against extracellular Salmonella enterica serovar Typhimurium, but not against Salmonella in macrophages.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Proteins; Cell Line; Ciprofloxacin; Colony Count, Microbial; Drug Antagonism; Gene Expression; Gene Expression Profiling; Macrophages; Membrane Transport Proteins; Mice; Microbial Viability; Salicylates; Salmonella typhimurium | 2010 |
On second-order calibration based on multivariate curve resolution in the presence of highly overlapped profiles.
Topics: Anti-Bacterial Agents; Calibration; Ciprofloxacin; Computer Simulation; Electrophoresis, Capillary; Fluoroquinolones; Least-Squares Analysis; Luminescent Measurements; Models, Chemical; Multivariate Analysis; Salicylates; Water | 2020 |